JP2014521636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521636A5 JP2014521636A5 JP2014522216A JP2014522216A JP2014521636A5 JP 2014521636 A5 JP2014521636 A5 JP 2014521636A5 JP 2014522216 A JP2014522216 A JP 2014522216A JP 2014522216 A JP2014522216 A JP 2014522216A JP 2014521636 A5 JP2014521636 A5 JP 2014521636A5
- Authority
- JP
- Japan
- Prior art keywords
- substrate
- peg
- group
- substrate according
- phospholipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000758 substrate Substances 0.000 claims 30
- 239000002202 Polyethylene glycol Substances 0.000 claims 11
- 150000002632 lipids Chemical class 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 229920001223 polyethylene glycol Polymers 0.000 claims 11
- 239000011159 matrix material Substances 0.000 claims 9
- 229920002988 biodegradable polymer Polymers 0.000 claims 8
- 239000004621 biodegradable polymer Substances 0.000 claims 8
- 150000003904 phospholipids Chemical class 0.000 claims 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 6
- 239000002904 solvent Substances 0.000 claims 5
- 229920000249 biocompatible polymer Polymers 0.000 claims 4
- -1 cationic lipid Chemical class 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 229930182558 Sterol Natural products 0.000 claims 3
- 235000012000 cholesterol Nutrition 0.000 claims 3
- 150000004665 fatty acids Chemical group 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- 150000003432 sterols Chemical class 0.000 claims 3
- 235000003702 sterols Nutrition 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims 2
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 claims 2
- KWVJHCQQUFDPLU-YEUCEMRASA-N 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KWVJHCQQUFDPLU-YEUCEMRASA-N 0.000 claims 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- 239000004793 Polystyrene Substances 0.000 claims 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims 2
- 239000004633 polyglycolic acid Substances 0.000 claims 2
- 239000004626 polylactic acid Substances 0.000 claims 2
- 229920002223 polystyrene Polymers 0.000 claims 2
- 125000005471 saturated fatty acid group Chemical group 0.000 claims 2
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 claims 1
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 1
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 claims 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 claims 1
- WLZPCFOGJNCCRJ-UHFFFAOYSA-M 4-ethenyl-1-ethylpyridin-1-ium;bromide Chemical compound [Br-].CC[N+]1=CC=C(C=C)C=C1 WLZPCFOGJNCCRJ-UHFFFAOYSA-M 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 claims 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 229930040373 Paraformaldehyde Natural products 0.000 claims 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims 1
- 239000004952 Polyamide Substances 0.000 claims 1
- 108010039918 Polylysine Proteins 0.000 claims 1
- 239000004743 Polypropylene Substances 0.000 claims 1
- ISXSJGHXHUZXNF-LXZPIJOJSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate;hydrochloride Chemical compound Cl.C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 ISXSJGHXHUZXNF-LXZPIJOJSA-N 0.000 claims 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 229920000229 biodegradable polyester Polymers 0.000 claims 1
- 239000004622 biodegradable polyester Substances 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000002449 bone cell Anatomy 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 claims 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 235000021588 free fatty acids Nutrition 0.000 claims 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-O glycerylphosphorylcholine Chemical compound C[N+](C)(C)CCO[P@](O)(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-O 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000011164 ossification Effects 0.000 claims 1
- 230000002188 osteogenic effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims 1
- 150000003905 phosphatidylinositols Chemical class 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- 229920006324 polyoxymethylene Polymers 0.000 claims 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 1
- 229920001155 polypropylene Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 239000001294 propane Substances 0.000 claims 1
- 150000003408 sphingolipids Chemical class 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 229930003799 tocopherol Natural products 0.000 claims 1
- 239000011732 tocopherol Substances 0.000 claims 1
- 235000019149 tocopherols Nutrition 0.000 claims 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512025P | 2011-07-27 | 2011-07-27 | |
| US61/512,025 | 2011-07-27 | ||
| PCT/IL2012/050278 WO2013014677A1 (en) | 2011-07-27 | 2012-07-26 | Matrix compositions for controlled release of peptide and polypeptide molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521636A JP2014521636A (ja) | 2014-08-28 |
| JP2014521636A5 true JP2014521636A5 (cg-RX-API-DMAC7.html) | 2015-09-10 |
Family
ID=47600590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014522216A Pending JP2014521636A (ja) | 2011-07-27 | 2012-07-26 | ペプチドおよびポリペプチド分子の制御放出のためのマトリクス組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20140271861A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2736492A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014521636A (cg-RX-API-DMAC7.html) |
| CN (1) | CN103717206A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012288422B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2838481A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013014677A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015114633A1 (en) | 2014-01-30 | 2015-08-06 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. | Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same |
| US10682442B2 (en) | 2014-04-04 | 2020-06-16 | University Of Kentucky Research Foundation | Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles |
| US11406742B2 (en) | 2014-07-18 | 2022-08-09 | M.A. Med Alliance SA | Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs |
| US9492594B2 (en) * | 2014-07-18 | 2016-11-15 | M.A. Med Alliance SA | Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs |
| US10182993B2 (en) * | 2015-04-06 | 2019-01-22 | Patheon Softgels Inc. | Compositions for colonic delivery of drugs |
| EP3700965A1 (en) | 2017-10-27 | 2020-09-02 | Massachusetts Institute of Technology | Poly (beta-amino esters) and uses thereof |
| WO2020086965A1 (en) * | 2018-10-26 | 2020-04-30 | Massachusetts Institute Of Technology | Polymer-lipids and compositions |
| WO2022192176A1 (en) | 2021-03-09 | 2022-09-15 | Massachusetts Institute Of Technology | Branched poly(-amino esters) for the delivery of nucleic acids |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9412273D0 (en) * | 1994-06-18 | 1994-08-10 | Univ Nottingham | Administration means |
| US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| MXPA03002918A (es) * | 2000-10-02 | 2004-04-20 | Arizeke Pharmaceuticals Inc | Composiciones y metodos para el transporte de agentes biologicamente activos a traves de barreras celulares. |
| AU2004211991B2 (en) * | 2003-02-12 | 2011-03-31 | Syncera, Inc. | Random and non-random alkylene oxide polymer alloy compositions |
| US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| DK1635875T3 (da) * | 2003-06-26 | 2009-01-12 | Psivida Inc | In-situ-geldannende lægemiddeladministrationssystem |
| US8277831B2 (en) * | 2004-02-17 | 2012-10-02 | Advanced Technologies And Regenerative Medicine, Llc. | Drug-enhanced adhesion prevention |
| CN101005828B (zh) * | 2004-06-17 | 2012-01-11 | 维尔恩公司 | 用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物 |
| JP2009534309A (ja) * | 2006-03-31 | 2009-09-24 | マサチューセッツ インスティテュート オブ テクノロジー | 治療剤の標的化送達のためのシステム |
| US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
| WO2008124634A1 (en) * | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
| CN104274866B (zh) * | 2008-07-14 | 2016-08-24 | 波利皮得有限公司 | 持续释放药物载体组合物 |
| US20120021036A1 (en) * | 2009-01-15 | 2012-01-26 | The Regents Of The University Of California | Composite nanostructures and methods for making and using them |
| CN101555212B (zh) * | 2009-05-22 | 2012-06-20 | 戴立忠 | 能输送生物活性物质的合成小分子化合物及其应用 |
| JP5738856B2 (ja) * | 2009-07-14 | 2015-06-24 | ポリピッド リミテッド | 徐放性薬物担体組成物 |
-
2012
- 2012-07-26 AU AU2012288422A patent/AU2012288422B2/en active Active
- 2012-07-26 WO PCT/IL2012/050278 patent/WO2013014677A1/en not_active Ceased
- 2012-07-26 JP JP2014522216A patent/JP2014521636A/ja active Pending
- 2012-07-26 CA CA2838481A patent/CA2838481A1/en not_active Abandoned
- 2012-07-26 US US14/235,075 patent/US20140271861A1/en not_active Abandoned
- 2012-07-26 EP EP12816978.6A patent/EP2736492A4/en not_active Withdrawn
- 2012-07-26 CN CN201280037604.2A patent/CN103717206A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014521636A5 (cg-RX-API-DMAC7.html) | ||
| Zupancic et al. | Controlled release of ciprofloxacin from core–shell nanofibers with monolithic or blended core | |
| JP2011528031A5 (cg-RX-API-DMAC7.html) | ||
| JP2012533334A5 (cg-RX-API-DMAC7.html) | ||
| Cheng et al. | Controlled co-delivery of growth factors through layer-by-layer assembly of core–shell nanofibers for improving bone regeneration | |
| Bae et al. | Heparin-eluting electrospun nanofiber yarns for antithrombotic vascular sutures | |
| Huang et al. | ROS-scavenging electroactive polyphosphazene-based core–shell nanofibers for bone regeneration | |
| Hyun et al. | In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier | |
| Lee et al. | Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis | |
| Jay et al. | Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking | |
| CA2521916C (en) | Biodegradable film having a honeycomb structure for the prevention of postoperative tissue adhesion | |
| US10010709B2 (en) | Composition for on-demand ultrasound-triggered drug delivery | |
| Bassand et al. | How agarose gels surrounding PLGA implants limit swelling and slow down drug release | |
| JP2013517265A5 (cg-RX-API-DMAC7.html) | ||
| PL215579B1 (pl) | Sposób otrzymywania osadu, osad otrzymany tym sposobem, kompozycja farmaceutyczna i wyrób medyczny | |
| Sharma et al. | Recent advances in polymer scaffolds for biomedical applications | |
| HK1249411A1 (zh) | 使用电纺丝制造含有药物的可生物降解的纤维状物质的方法 | |
| US11980535B2 (en) | Method of using a cardiovascular graft to reduce thrombosis or platelet adhesion | |
| Kanth et al. | Recent advancements and perspective of ciprofloxacin-based antimicrobial polymers | |
| WO2013003157A1 (en) | Cell-free tissued engineered vascular grafts | |
| US20120004199A1 (en) | Scaffolds | |
| BR112014017836B1 (pt) | composição de enchimento ósseo | |
| Furuhashi et al. | Titanium membrane layered between fluvastatin-loaded poly (lactic-co-glycolic) acid for guided bone regeneration | |
| Ziemba et al. | Lactonic sophorolipid increases surface wettability of poly-L-lactic acid electrospun fibers | |
| Govindarajan et al. | Nanoscaled biodegradable metal–polymeric three-dimensional framework for endothelial cell patterning and sustained angiogenesis |